Hyundai Bioscience Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-22,128	-6,930	-14,499	-15,807	-20,051
Depreciation & Amortization	1,306	633.82	1,435	1,782	2,703
Asset Writedown & Restructuring Costs	-	-	4,769	-	7,517
Loss (Gain) From Sale of Investments	9.04	-14.05	-123.67	-910.99	-
Loss (Gain) on Equity Investments	4,766	5,730	-	-8,834	-93.91
Stock-Based Compensation	22.6	-77.98	402.42	596.94	578.26
Provision & Write-off of Bad Debts	89.74	156.13	-28.78	5,260	-583.99
Other Operating Activities	673.67	2,717	911.44	-79.49	3,925
Change in Accounts Receivable	-2,170	43.52	864.23	1,184	3,526
Change in Inventory	-161.99	1,374	358.12	403.6	864.9
Change in Accounts Payable	-57.7	447.9	-256.2	503.57	13.43
Change in Other Net Operating Assets	601.48	-1,824	159.77	-642.06	1,063
Operating Cash Flow	-17,050	2,257	-6,008	-16,544	-538.48
Capital Expenditures	-1,194	-169.57	-539.7	-1,544	-3,747
Sale (Purchase) of Intangibles	-19,000	-2,000	-47.84	-	-15.12
Investment in Securities	-19,836	-16,934	6,000	10,210	-13,010
Other Investing Activities	1,233	-773.14	-557	-0.4	1,773
Investing Cash Flow	-38,586	-19,740	5,177	8,518	-12,359
Long-Term Debt Issued	14,845	20,001	-	-	-
Total Debt Issued	14,845	20,001	-	-	-
Short-Term Debt Repaid	-5,000	-400	-500	-500	-
Long-Term Debt Repaid	-19,386	-116.58	-362.88	-1,194	-1,246
Total Debt Repaid	-24,386	-516.58	-862.88	-1,694	-1,246
Net Debt Issued (Repaid)	-9,541	19,484	-862.88	-1,694	-1,246
Issuance of Common Stock	84,258	139.96	1,094	3,596	4,449
Other Financing Activities	-344.38	-434.78	-289.18	-229.04	-209.66
Financing Cash Flow	74,373	19,190	-57.97	1,673	2,994
Foreign Exchange Rate Adjustments	-56.06	138.47	-31.72	-103.42	-122.29
Miscellaneous Cash Flow Adjustments	-0	0	-	-	-
Net Cash Flow	18,681	1,845	-920.54	-6,456	-10,026
Free Cash Flow	-18,244	2,087	-6,548	-18,087	-4,285
Free Cash Flow Margin	-518.69%	13.87%	-69.06%	-230.36%	-46.37%
Free Cash Flow Per Share	-0.17	0.16	-82.31	-229.72	-58.04
Cash Interest Paid	344.38	434.78	289.18	222.4	209.66
Cash Income Tax Paid	136.58	-54.28	19.19	-17.99	78.92
Levered Free Cash Flow	-31,915	-2,581	-4,900	-8,388	1,337
Unlevered Free Cash Flow	-30,393	-1,135	-4,704	-8,108	3,214
Change in Working Capital	-1,788	41.17	1,126	1,449	5,467

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.